NSGC 2026 has ended. This guide stays up as the record of who was there. Next: NSGC 2027, Nov 7–11, 2027 in Tampa
Alexion, AstraZeneca Rare Disease at NSGC 2026
Nov 10–14, 2026 Baltimore, MD ~2.5k attendees Website
Alexion, AstraZeneca Rare Disease takes part in 1 session at NSGC 2026 in Baltimore, and exhibits at Booth 1155. Its lunch symposium goes over the clinical clues that point to hypophosphatasia, lysosomal acid lipase deficiency and neurofibromatosis type 1, so clinicians can recognize them earlier. As AstraZeneca's rare disease company, it has medicines for these conditions and for complement disorders.
| Organization | NSGC 2026 Attendance |
|---|---|
Alexion, AstraZeneca Rare Disease Boston, MA | |
AstraZeneca's rare disease company, with medicines for conditions including hypophosphatasia, lysosomal acid lipase deficiency, neurofibromatosis type 1 and complement disorders. | Booth Exhibiting at Booth 1155 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Fri Nov 13 12:15–1:30pm Recognize What Might Be Missed: Changing the Patient Journey in HPP, LAL-D, NF1 Reviews the clinical clues to hypophosphatasia, lysosomal acid lipase deficiency and neurofibromatosis type 1, to help clinicians recognize them earlier. |
Find decision makers at Alexion, AstraZeneca Rare Disease
Tell us what you sell and we’ll find the people at Alexion, AstraZeneca Rare Disease most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the National Society of Genetic Counselors (NSGC). Organization details are derived from NSGC’s published exhibitor list and program, and each organization’s own website. Submit a correction